Regulations.gov document
Migraine: Developing Drugs for Acute Treatment; Draft Guidance for Industry; Availability
Notice · FDA-2014-D-1540 · posted Oct 22, 2014
Key facts
| Document ID | FDA-2014-D-1540-0001 |
|---|---|
| Title | Migraine: Developing Drugs for Acute Treatment; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2014-D-1540 |
| Posted | Oct 22, 2014 |
| Federal Register citation | 79 FR 63129 |
| FR document number | 2014-25048 |
| Comment period opens | Oct 22, 2014 |
| Comments due | Dec 23, 2014 |
| Effective date | Oct 22, 2014 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: